Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
AiCure
AddedFeb 15, 2024
UpdatedJun 18, 2026
AiCure

AiCure

NY-based Ai Cure Technologies LLC specializes in developing and modifying computer software.

HQ
New York City, NY, US
Founded
2009
Overview
Compare
Fundraising
Employees
Website

Founded in New York, AiCure specializes in developing AI-powered software aimed at enhancing patient engagement in clinical trials. The company's core mission is to revolutionize the way clinical trial participants are monitored and supported, ensuring better adherence and engagement through advanced technology. AiCure's platform employs computer vision, synchronous chat, and predictive analytics to provide comprehensive support to participants via their smartphones, thereby extending the reach of care teams and improving trial outcomes.

Notable figures associated with AiCure include experts in AI and healthcare technology, although specific names are not provided. The company has attracted significant investment from prominent venture capital firms, underscoring its innovative approach. Key achievements include the development of the world's first AI-driven patient engagement platform, which has had a substantial impact on clinical trial efficiency and participant experience. AiCure's technology has set a new standard in the industry, demonstrating the transformative potential of AI in healthcare.

AiCure - Similar Companies

PatientIQ logo

PatientIQ

patientiq.io

Curebase logo

Curebase

curebase.com

CipherHealth logo

CipherHealth

cipherhealth.com

HealthTalk A.I. logo

HealthTalk A.I.

healthtalkai.com

Leapcure logo

Leapcure

leapcure.com

Leal Health logo

Leal Health

leal.health

Courier Health logo

Courier Health

courierhealth.com

Outcomes4Me logo

Outcomes4Me

Clinical.Ly logo

Clinical.Ly

clinical.ly

CuraPatient logo

CuraPatient

curapatient.com

Medrio logo

Medrio

medrio.com

VitalTrax logo

VitalTrax

vitaltrax.net

ClinCapture logo

ClinCapture

clincapture.com

Tact.ai logo

Tact.ai

tact.ai

Datacubed Health logo

Datacubed Health

datacubed.com

AiCure - Quick Facts

Who are AiCure's competitors?

Companies similar to AiCure include PatientIQ, Curebase, CipherHealth and HealthTalk A.I..

When was AiCure founded?

AiCure was founded in 2009.

Where is AiCure's headquarters located?

AiCure's headquarters is located in New York City, NY, US.

When was AiCure's last funding round?

AiCure's most recent funding round was for $12M (USD) in January 2024.

How much has AiCure raised to-date?

As of Jan 23, 2024, AiCure has raised a total of $68.8M (USD).

How many employees does AiCure have?

AiCure has 84 employees as of Feb 4, 2024.

AiCure - Classification

Ownership
  • Private
  • Venture Capital
Technology
  • AI
  • Analytics
Geographic Exposure
  • Americas
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Patient Engagement
Tags
  • Healthtech
  • SaaS
NAICS
  • 513200Software Publishers
  • 510000Information
  • 513000Publishing Industries
  • 513210Software Publishers
SIC
  • 7300Business Services
  • 7370Computer Programming, Data Processing, And Other Computer Related
  • 7372Prepackaged Software
ISIC
  • 6202Computer consultancy and computer facilities management activities
Show 6 more industry codes
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541500Computer Systems Design and Related Services
  • 541512Computer Systems Design Services
  • 541000Professional, Scientific, and Technical Services
  • 541510Computer Systems Design and Related Services
SIC
  • 7373Computer Integrated Systems Design